Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Plasma Medicine Life Sciences is a biotechnology company focused on the development and commercialization of Cold Atmospheric Plasma (CAP) technology for medical applications. The company's platform utilizes ionized gas at room temperature to generate reactive oxygen and nitrogen species, which have demonstrated therapeutic potential in wound healing, sterilization, and oncology. By leveraging the unique physical and chemical properties of plasma, the company aims to provide non-invasive, drug-free solutions for chronic wounds and resistant infections. Their research is currently centered on optimizing plasma delivery systems for clinical settings and exploring synergistic effects with existing therapies.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Plasma Medicine Life Sciences.